Abstract
Congenital heart defects (CHD) are the most common congenital problems in neonates. The basis for CHD is multifactorial, involving genetic and environmental components. The elucidation of genetic components remains difficult because it is a genetically heterogeneous disease. Currently, the major identified genetic causes include chromosomal abnormalities, large subchromosomal deletions/duplications, and point mutations. However, much more remains to be unraveled. An important insight from the research on the genetics of CHD is that any change at the genetic level that alters the dosage of genes required in any process during heart development results in a developmental defect. The use of conventional gene identification (linkage analysis and direct targeted sequencing) methods followed by the rapid advancements in high-throughput technologies (copy number variant platforms, SNP arrays, and next-generation sequencing) has identified an extensive list of genetic causes. However, the most common presentation of CHD is in the form of sporadic cases. Therefore, it is important to identify their underlying genetic cause. In this review, we revisit the causal genetic factors of CHD and discuss the clinical implications of research in the field.
Similar content being viewed by others
References
Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39(12):1890–1900
Pate N, Jawed S, Nigar N, Junaid F, Wadood AA, Abdullah F (2016) Frequency and pattern of congenital heart defects in a tertiary care cardiac hospital of Karachi. Pak J Med Sci. 32(1):79
Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control: World Health Organization; 2011.
Hersh JH, Angle B, Fox TL, Barth RF, Bendon RW, Gowans G (2002) Developmental field defects: coming together of associations and sequences during blastogenesis. Am J Med Genet Part A. 110(4):320–323
Franklin RC, Jacobs JP, Tchervenkov CI, Béland MJ (2002) Bidirectional crossmap of the Short Lists of the European Paediatric Cardiac Code and the International Congenital Heart Surgery Nomenclature and Database Project. Cardiol Young 12(S2):18–22
American Heart Association. 2017.
Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN et al (2016) Congenital heart defects in the United States. Circulation 134(2):101–109
Jacobson B. Circulatory Changes at Birth. Embryo Project Encyclopedia. 2012.
Poglavlja O. Robbins and Cotran Pathologic Basis of Disease 8th Edition.
Maillet M, Van Berlo JH, Molkentin JD (2013) Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol 14(1):38
Shahzad M, Waqar T, Waheed KAI, Gul R, Fatima ST (2017) Pulse oximetry as a screening tool for critical congenital heart defects in newborns. JPMA J Pak Med Ass. 67(8):1220
Fahed AC, Gelb BD, Seidman J, Seidman CE (2013) Genetics of Congenital Heart Disease. Circ Res. 112(4):707–720
Blalock A, Taussig HB (1945) The surgical treatment of malformations of the heart: in which there is pulmonary stenosis or pulmonary atresia. J Am Med Assoc 128(3):189–202
Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014:CIRCULATIONAHA. 113.008396.
Kopf PG, Walker MK (2009) Overview of developmental heart defects by dioxins, PCBs, and pesticides. Journal of Environmental Science and Health, Part C 27(4):276–285
Zhu H, Kartiko S, Finnell R (2009) Importance of gene–environment interactions in the etiology of selected birth defects. Clin Genet. 75(5):409–423
Fahed A, Gelb B, Seidman J, Seidman C. Genetics of congenital heart disease: the glass half empty (vol 112, pg 707, 2013). Circulation research. 2013;112(12):E182-E.
van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ et al (2011) Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol 58(21):2241–2247
Nora JJ, Dodd PF, McNamara DG, Hattwick MA, Leachman RD, Cooley DA (1969) Risk to offspring of parents with congenital heart defects. JAMA 209(13):2052–2053
Øyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M (2009) Recurrence of congenital heart defects in families. Circulation 120(4):295–301
Zaidi S, Brueckner M (2017) Genetics and genomics of congenital heart disease. Circ Res. 120(6):923–940
Shieh JT, Bittles AH, Hudgins L (2012) Consanguinity and the risk of congenital heart disease. Am J Med Genet Part A. 158(5):1236–1241
Goenezen S, Rennie MY, Rugonyi S (2012) Biomechanics of early cardiac development. Biomech Model Mechanobiol 11(8):1187–1204
Basson CT, Cowley GS, Solomon SD, Weissman B, Poznanski AK, Traill TA et al (1994) The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med. 330(13):885–891
McGregor TL, Misri A, Bartlett J, Orabona G, Friedman RD, Sexton D et al (2010) Consanguinity mapping of congenital heart disease in a South Indian population. PLoS ONE 5(4):e10286
Wooten EC, Iyer LK, Montefusco MC, Hedgepeth AK, Payne DD, Kapur NK et al (2010) Application of gene network analysis techniques identifies AXIN1/PDIA2 and endoglin haplotypes associated with bicuspid aortic valve. PLoS ONE 5(1):e8830
Keavney B, Mamasoula C, Hall D, Topf A, Griffin H, Rahman T, et al. A Common Variant in the PTPN11 Gene Contributes to the Risk of Tetralogy of Fallot. Am Heart Assoc; 2011.
Hartman RJ, Rasmussen SA, Botto LD, Riehle-Colarusso T, Martin CL, Cragan JD et al (2011) The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol. 32(8):1147–1157
Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S (2004) Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet. 5(10):725–738
Bondy CA (2009) Turner syndrome 2008. Hormone Research in Paediatrics. 71(Suppl. 1):52–56
Pont SJ, Robbins JM, Bird T, Gibson JB, Cleves MA, Tilford JM et al (2006) Congenital malformations among liveborn infants with trisomies 18 and 13. Am J Med Genet Part A. 140(16):1749–1756
Wimalasundera R, Gardiner H (2004) Congenital heart disease and aneuploidy. Prenat Diagn. 24(13):1116–1122
Grossman TR, Gamliel A, Wessells RJ, Taghli-Lamallem O, Jepsen K, Ocorr K et al (2011) Over-expression of DSCAM and COL6A2 cooperatively generates congenital heart defects. PLoS Genet. 7(11):e1002344
Carvalho CM, Lupski JR (2016) Mechanisms underlying structural variant formation in genomic disorders. Nat Rev Genet. 17(4):224–238
Glessner J, Bick AG, Ito K, Homsy J, Rodriguez-Murillo L, Fromer M, et al. Increased frequency of de novo copy number variations in congenital heart disease by integrative analysis of SNP array and exome sequence data. Circ Res. 2014:CIRCRESAHA. 114.304458.
Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM et al (2001) TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104(4):619–629
Pehlivan T, Pober BR, Brueckner M, Garrett S, Slaugh R, Van Rheeden R, et al. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23. 1 and congenital heart disease. Am J Med Genet Part A. 1999;83(3):201–6.
Nickerson E, Greenberg F, Keating MT, McCaskill C, Shaffer LG. Deletions of the elastin gene at 7q11. 23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet. 1995;56(5):1156.
Ye M, Coldren C, Liang X, Mattina T, Goldmuntz E, Benson DW et al (2009) Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. Hum Mol Genet. 19(4):648–656
Ta-Shma A, Frumkin A, Rein AJ, Yaacov B, Werner M, Elpeleg O et al (2014) A human laterality disorder associated with a homozygous WDR16 deletion. Eur J Hum Genet. 23(9):1262
Andreassi MG, Della CA (2016) Genetics of bicuspid aortic valve aortopathy. Curr Opin Cardiol. 31(6):585–592
Soemedi R, Wilson IJ, Bentham J, Darlay R, Töpf A, Zelenika D et al (2012) Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet. 91(3):489–501
McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA et al (2006) NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. The American Journal of Human Genetics. 79(1):169–173
Mori AD, Bruneau BG (2004) TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol. 19(3):211–215
Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29(4).
Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME et al (2010) Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics 126(4):746–759
Metcalfe K, Rucka AK, Smoot L, Hofstadler G, Tuzler G, McKeown P et al (2000) Elastin: mutational spectrum in supravalvular aortic stenosis. European journal of human genetics: EJHG. 8(12):955
Bauer RC, Laney AO, Smith R, Gerfen J, Morrissette JJ, Woyciechowski S et al (2010) Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum Mutat. 31(5):594–601
McElhinney DB, Geiger E, Blinder J, Benson DW, Goldmuntz E. NKX2. 5mutations in patients with congenital heart disease. J Am coll cardiol. 2003;42(9):1650–5.
Heathcote K, Braybrook C, Abushaban L, Guy M, Khetyar ME, Patton MA, et al. Common arterial trunk associated with a homeodomain mutation of NKX2. 6. Hum Mol Genet. 2005;14(5):585–93.
Peng T, Wang L, Zhou S-F, Li X. Mutations of the GATA4 and NKX2. 5 genes in Chinese pediatric patients with non-familial congenital heart disease. Genetica. 2010;138(11–12):1231–40.
Wei D, Bao H, Zhou N, Zheng G-F, Liu X-Y, Yang Y-Q (2013) GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect. Pediatr Cardiol. 34(3):504–511
Zheng G-F, Wei D, Zhao H, Zhou N, Yang Y-Q, Liu X-Y (2012) A novel GATA6 mutation associated with congenital ventricular septal defect. Int J Mol Med. 29(6):1065–1071
Cheng Z, Wang J, Su D, Pan H, Huang G, Li X et al (2011) Two novel mutations of the IRX4 gene in patients with congenital heart disease. Hum Genet 130(5):657–662
Posch MG, Gramlich M, Sunde M, Schmitt KR, Lee SH, Richter S et al (2010) A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet. 47(4):230–235
Ware SM, Peng J, Zhu L, Fernbach S, Colicos S, Casey B et al (2004) Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects. Am J Hum Genet. 74(1):93–105
Kasahara H, Lee B, Schott J-J, Benson DW, Seidman J, Seidman CE, et al. Loss of function and inhibitory effects of human CSX/NKX2. 5 homeoprotein mutations associated with congenital heart disease. J Clin Invest. 2000;106(2):299.
Moskowitz IP, Wang J, Peterson MA, Pu WT, Mackinnon AC, Oxburgh L et al (2011) Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. Proc Natl Acad Sci 108(10):4006–4011
Moskowitz IP, Kim JB, Moore ML, Wolf CM, Peterson MA, Shendure J et al (2007) A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 129(7):1365–1376
Burdine RD, Schier AF (2000) Conserved and divergent mechanisms in left–right axis formation. Genes Dev. 14(7):763–776
Mohapatra B, Casey B, Li H, Ho-Dawson T, Smith L, Fernbach SD et al (2008) Identification and functional characterization of NODAL rare variants in heterotaxy and isolated cardiovascular malformations. Hum Mol Genet. 18(5):861–871
Kosaki K, Kosaki R, Bassi M, Lewin M, Belmont J, Schauer G et al (1999) Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development. The American Journal of Human Genetics. 64(3):712–721
Ching Y-H, Ghosh TK, Cross SJ, Packham EA, Honeyman L, Loughna S et al (2005) Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet. 37(4):423–428
Postma AV, van Engelen K, van de Meerakker J, Rahman T, Probst S, Baars MJ et al (2011) Mutations in the Sarcomere Gene MYH7 in Ebstein AnomalyClinical Perspective. Cir Cradiovas Genet. 4(1):43–50
Acknowledgement
Prof. Philippa Talmud, Center for Cardiovascular Genetics, Institue of Cardiovascular Sciences, University College London, UK is acknowledged for the critical revision of the review for English, grammar, and punctuation.
Funding
We received no specific funding for this review.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest:
All authors declare that they have no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shabana, N., Shahid, S.U. & Irfan, U. Genetic Contribution to Congenital Heart Disease (CHD). Pediatr Cardiol 41, 12–23 (2020). https://doi.org/10.1007/s00246-019-02271-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-019-02271-4